3d
Here's What Certain Changes In Your Nails Can Reveal About Your Health, According To Dermatologists
In reality, nails are considered appendages of the skin, explains Chris Adigun, MD, a board-certified dermatologist and nail ...
The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has ...
The US FDA has accepted Sun Pharmaceutical's supplemental Biologics License Application (sBLA) for ILUMYA, a treatment for ...
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced that the US ...
An informational industry analysis examining ingredient-level research, marketing positioning trends, regulatory context, and ...
Sun Pharmaceutical Industries Limited. Sun Pharma announces US FDA acceptance of supplemental Biologics License Application ...
Not sure if that green spot is fungus? Dermatologists explain green nail syndrome, the causes, the best next steps, and how ...
If the sBLA is approved, expansion into psoriatic arthritis would build on the established clinical experience of ILUMYA as an IL-23 inhibitor for moderate-to-severe ...
Key Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results